Synnovation Therapeutics, a precision medicine company developing small molecule therapies optimised to achieve best-in-class pharmacology against highly validated disease targets, launched today with a $102 million Series A.
Cognizant have announced an expanded agreement with Takeda a global biopharmaceutical company, to support the company’s digital transformation strategy by reinforcing and supporting its technology efforts.
Gerresheimer, a manufacturer for the pharma and life science industry, will invest more than $88 million in expanding its manufacturing operations in Peachtree City, creating over 200 new jobs for Fayette County.
In this article, Dr. Asma Patel, Vice President of Integrated Development Services at Quotient Sciences, explores the benefits of MR formulations, highlighting the importance of an effective strategy for MR development.
Futura Medical plc has extended until January 2029 its exclusive licensing agreement with Cooper Consumer Health to commercialise Eroxon, the Company's topical, gel-based Erectile Dysfunction treatment.
John Cardone, Marketing Manager, Custom Antibodies, Bio-Rad Laboratories explores Monitoring Antibody Drug Safety and Efficacy in Preclinical and Clinical Development in our latest EPM insight.
EirGen Pharma has announced the commencement of works in its new plant in the IDA Industrial Estate, including a €20 million internal refit and additional Plant rooms expanding its Oral Solid Dose manufacturing and packaging capabilities.
Isomorphic Labs have announced that it has entered into a strategic research collaboration with Eli Lilly and Company and a strategic research collaboration with Novartis to discover small molecule therapeutics against three undisclosed targets.
WuXi AppTec have announced the commissioning of two new peptide manufacturing plants, one at its Changzhou facility and another at the new Taixing site in China.
